Physician profile
Crista Prates
NPI 1023531571
$8,729.99
in general payments reported to CMS, 2019-2025
12 companies · $8,386 in 2025
The $8,386 reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2023: $15.99 · 2024: $216 · 2025: $8,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,053 · Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,052.50 |
| Food and Beverage | $566.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $7,012.50 | 2025 | Immunocap |
| Novartis Pharmaceuticals Corporation | $1,040.00 | 2025 | |
| Glaxosmithkline, LLC. | $216.49 | 2021-2025 | Benlysta |
| Amgen INC. | $171.08 | 2021-2025 | Otezla, Enbrel, Otezla |
| Janssen Biotech, INC. | $114.93 | 2021-2025 | Simponi Aria, Tremfya |
| Abbvie INC. | $48.55 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.87 | 2024 | Cyltezo |
| E.R. Squibb & Sons, L.L.C. | $21.32 | 2025 | Orencia |
| Actelion Pharmaceuticals US, INC. | $20.24 | 2025 | Opsumit, Uptravi |
| Aurinia Pharma U.S., INC. | $19.74 | 2024 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $15.99 | 2023 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crista Prates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.